Not applicableWithdrawnNCT07292285What this trial is testingThe Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial.Who this might be right forCancer of the Rectum University of Colorado, Denver
Not applicableNot Yet RecruitingNCT07775859What this trial is testingNOMAD-GI: Molecular-guided Non-operative Management and Organ Preservation Strategy After Precision Therapy in Gastrointestinal CancersWho this might be right forGastrointestinal CancerGastric CancerGastroesophageal Junction Cancer+2 more Peking University Cancer Hospital & Institute 200
Not applicableUnknownNCT03426397What this trial is testing"Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal CancerWho this might be right forRectal Neoplasms The Netherlands Cancer Institute 220
Large-scale testing (Phase 3)Study completedNCT00112931What this trial is testingRituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's LymphomaWho this might be right forLymphoma University College, London 462
Post-approval studies (Phase 4)Not Yet RecruitingNCT07483060What this trial is testingNext Generation STAR-TREC (NG-ST) - Organ Preservation in Early Rectal CancerWho this might be right forRectal Cancer Vastra Gotaland Region 90
Not applicableLooking for participantsNCT06209099What this trial is testingOrgan Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal CancerWho this might be right forRectal Cancer Peking University Cancer Hospital & Institute 96
Large-scale testing (Phase 3)Looking for participantsNCT06762405What this trial is testingPRODIGE 90 - (FFCD 2204) Neoadjuvant Dostarlimab with Short Course Radiotherapy in a Watch-and-wait Strategy for Microsatellite Unstable or Mismatch Repair-deficient Locally Advanced Rectal Cancer PatientsWho this might be right forRectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) Centre Hospitalier Universitaire Dijon 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07409844What this trial is testingNeoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon CancerWho this might be right forDMMR Colorectal CancerColon Cancer Stage IColon Cancer Stage II/III+2 more Ismail Gögenur 152
Testing effectiveness (Phase 2)Study completedNCT04696757What this trial is testingNon-OpeRative MANagement of Rectal Cancer PatientsWho this might be right forRectal CancerChemoradiotherapyWatch & Wait Kangbuk Samsung Hospital 18
Not applicableStudy completedNCT02298855What this trial is testingIndividualised Versus Conventional Medical Follow-up for Women After Primary Treatment for Ovarian Cancer.Who this might be right forOvarian Cancer University College, London 113
Not applicableLooking for participantsNCT04743102What this trial is testingMulti-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal CancerWho this might be right forRectal CancerNeoadjuvant TherapyComplete Remission+1 more Beijing Chao Yang Hospital 260
Not applicableLooking for participantsNCT07260526What this trial is testingResponse-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait StrategyWho this might be right forRectal Cancer West China Hospital 60
Not applicableNot Yet RecruitingNCT07410715What this trial is testingSurgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma (SWITCH)Who this might be right forHCC - Hepatocellular CarcinomaWatch & WaitSurgery West China Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT06059495What this trial is testingDEWI: Watch-and-Wait With Dostarlimab in Localized dMMR/MSI-H Gastric/GEJ Adenocarcinoma Phase II StudyWho this might be right forAdenocarcinoma - GEJGastric Adenocarcinoma GERCOR - Multidisciplinary Oncology Cooperative Group 89
Testing effectiveness (Phase 2)Looking for participantsNCT05939661What this trial is testingSingle-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal CancerWho this might be right forRectal Cancer Osaka University 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07783594What this trial is testingRandomized Phase 2 Study Of Epcoritamab Vs Watch And Wait InPatients With Previously Untreated Low Tumor Burden FollicularLymphomaWho this might be right forRandomizedPhase 2Epcoritamab+4 more M.D. Anderson Cancer Center 40
Not applicableEnded earlyNCT03402477What this trial is testing"Watch and Wait" After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.Who this might be right forRectal Cancer Helse Stavanger HF 86
Testing effectiveness (Phase 2)Study completedNCT04009876What this trial is testingEvaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal CancerWho this might be right forLocally Advanced Rectal Cancer (LARC) Fundación de investigación HM 30
Large-scale testing (Phase 3)UnknownNCT05081687What this trial is testingBrazilian Total Neoadjuvant Therapy TrialWho this might be right forColorectal Neoplasms Hospital Israelita Albert Einstein 150
Testing effectiveness (Phase 2)Looking for participantsNCT06812728What this trial is testingNeoadjuvant FOLFIRINOX and Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer PatientsWho this might be right forRectum Cancer Menoufia University 100